Growth Metrics

Verrica Pharmaceuticals (VRCA) Leases (2021 - 2025)

Historic Leases for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $1.0 million.

  • Verrica Pharmaceuticals' Leases fell 6021.22% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 6021.22%. This contributed to the annual value of $1.2 million for FY2024, which is 1786.48% down from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Leases stood at $1.0 million for Q3 2025, which was down 6021.22% from $945000.0 recorded in Q2 2025.
  • In the past 5 years, Verrica Pharmaceuticals' Leases registered a high of $2.6 million during Q3 2024, and its lowest value of $945000.0 during Q2 2025.
  • For the 5-year period, Verrica Pharmaceuticals' Leases averaged around $1.5 million, with its median value being $1.4 million (2022).
  • Per our database at Business Quant, Verrica Pharmaceuticals' Leases skyrocketed by 9708.74% in 2024 and then tumbled by 6255.94% in 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Leases (Quarter) stood at $1.6 million in 2021, then fell by 10.26% to $1.4 million in 2022, then decreased by 2.63% to $1.4 million in 2023, then dropped by 17.86% to $1.2 million in 2024, then decreased by 9.01% to $1.0 million in 2025.
  • Its Leases was $1.0 million in Q3 2025, compared to $945000.0 in Q2 2025 and $1.0 million in Q1 2025.